FILING ANALYSIS · FRIDAY, OCTOBER 30
IRADIMED CORP IRMD — 8-K: Results of Operations and Financial Condition
positive
Iradimed reported a 14% year-over-year revenue increase to $24.2 million and raised its full-year revenue guidance to $91.6-93.1 million, with GAAP diluted EPS expected to be $1.90-1.94
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →